Immediate Impact
39 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
2025 Standout
Works of Millie Garg being referenced
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
2018
The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Millie Garg | 287 | 181 | 48 | 58 | 13 | 374 | |
| Bronwen Needham | 271 | 183 | 40 | 55 | 6 | 340 | |
| Roxanne Strachan | 291 | 76 | 25 | 23 | 17 | 403 | |
| A. De Alessandri | 212 | 82 | 20 | 24 | 20 | 378 | |
| Rosaria Casciaro | 271 | 53 | 11 | 27 | 27 | 340 | |
| Evelien R. van Meel | 95 | 80 | 27 | 15 | 23 | 369 | |
| Fredrik Stenius | 39 | 164 | 73 | 17 | 11 | 386 | |
| Barbara Messore | 318 | 39 | 21 | 26 | 16 | 381 | |
| Chia-Yin Chin | 104 | 174 | 11 | 23 | 9 | 422 | |
| C. Shortt | 289 | 96 | 5 | 13 | 13 | 342 | |
| J McGaw | 199 | 73 | 27 | 17 | 16 | 352 |
All Works
Loading papers...